Yahoo Web Search

Search results

    • Maáza Martin

      Los Angeles Times· 1 day ago

      During her four-year tenure at Tarsus, Maáza Martin has spearheaded marketing and strategic planning efforts for XDEMVY, Tarsus' pioneering FDA-approved therapy for Demodex blepharitis.